Antiplatelet agents in the prevention of diabetic vascular complications
- 1 October 1993
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 9 (3) , 177-188
- https://doi.org/10.1002/dmr.5610090303
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Low-dose aspirin and stroke. "It ain't necessarily so".Stroke, 1992
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Thromboxane Biosynthesis and Platelet Function in Type I Diabetes MellitusNew England Journal of Medicine, 1988
- DipyridamoleNew England Journal of Medicine, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- SPECIFIC THROMBOXANE SYNTHETASE INHIBITION AND ALBUMIN EXCRETION RATE IN INSULIN-DEPENDENT DIABETESThe Lancet, 1984
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983